4.6 Article

MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations

期刊

BRAIN STIMULATION
卷 5, 期 4, 页码 577-585

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2011.12.002

关键词

Schizophrenia; Transcranial magnetic stimulation; Auditory hallucinations; Clinical trial

资金

  1. Canadian Institutes of Health Research Industry Partnered (Brainsway Ltd.) operating grant
  2. Hoffmann La Roche
  3. Alfried Krupp von Bohlen und Halbach Foundation
  4. CIHR Industry Partnered (Medtronic Inc) Investigator Award
  5. NHMRC
  6. Neuronetics Inc
  7. Aspect Medical Inc
  8. Ontario Mental Health Foundation (OMHF)
  9. Canadian Institutes of Health Research (CIHR) Clinician Scientist Award
  10. CIHR Fellowship
  11. National Health and Medical Research Council (NHMRC) Practitioner Fellowship
  12. National Alliance for Research on Schizophrenia and Depression (NARSAD) Lieber Young Investigator award

向作者/读者索取更多资源

Background: Repetitive transcranial magnetic stimulation (rTMS) has shown promise as a treatment for refractory auditory hallucinations (AH) in Schizophrenia. Most previous studies have examined the effect of low frequency, left-sided stimulation (LFL) (1 Hz) to the temporoparietal cortex (TPC). Priming stimulation (6 Hz) prior to LFL stimulation (hereby simply referred to as priming) has been shown to enhance the neurophysiological effects of LFL rTMS alone and, as such, may lead to greater attenuation of AH. Objective: Therefore, this study evaluated the efficacy of priming rTMS and LFL rTMS compared to sham rTMS using MRI targeting of Heschl's gyrus (HG) within the TPC of subjects with SCZ experiencing refractory auditory hallucinations (AH). Methods: Subjects between the ages of 18 and 65 were recruited from a tertiary care university hospital. Fifty-four subjects with medication resistant AH were randomized to receive LFL, priming, or sham rTMS for 20 treatments. The primary outcome was reduction of hallucinatory symptoms as indexed by response rates on the Psychotic Symptoms Rating Scale (PSYRATS). Results: The response rates did not differ among the three treatment groups using an intention to treat analysis. The response rates did not differ in any of the secondary outcome measures. The treatment was well tolerated with minimal adverse effects including no changes in cognition during the study. Conclusion: These findings suggest that neither priming nor LFL rTMS of Heschl's gyrus are effective at ameliorating refractory AH in schizophrenia. ClinicalTrials.gov Identifier: NCT01386918 (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据